Search Results - "Siner, Joshua I"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Minimal modification in the factor VIII B-domain sequence ameliorates the murine hemophilia A phenotype by Siner, Joshua I., Iacobelli, Nicholas P., Sabatino, Denise E., Ivanciu, Lacramiora, Zhou, Shangzhen, Poncz, Mortimer, Camire, Rodney M., Arruda, Valder R.

    Published in Blood (23-05-2013)
    “…Recombinant canine B-domain deleted (BDD) factor VIII (FVIII) is predominantly expressed as a single-chain protein and exhibits greater stability after…”
    Get full text
    Journal Article
  2. 2

    Safety of liver gene transfer following peripheral intravascular delivery of adeno-associated virus (AAV)-5 and AAV-6 in a large animal model by Favaro, Patricia, Finn, Jonathan D, Siner, Joshua I, Wright, J Fraser, High, Katherine A, Arruda, Valder R

    Published in Human gene therapy (01-07-2011)
    “…Intravascular delivery of adeno-associated virus (AAV) vector is commonly used for liver-directed gene therapy. In humans, the high prevalence of neutralizing…”
    Get more information
    Journal Article
  3. 3

    AAV liver expression of FIX-Padua prevents and eradicates FIX inhibitor without increasing thrombogenicity in hemophilia B dogs and mice by Crudele, Julie M., Finn, Jonathan D., Siner, Joshua I., Martin, Nicholas B., Niemeyer, Glenn P., Zhou, Shangzhen, Mingozzi, Federico, Lothrop, Clinton D., Arruda, Valder R.

    Published in Blood (05-03-2015)
    “…Emerging successful clinical data on gene therapy using adeno-associated viral (AAV) vector for hemophilia B (HB) showed that the risk of cellular immune…”
    Get full text
    Journal Article
  4. 4

    Circumventing furin enhances factor VIII biological activity and ameliorates bleeding phenotypes in hemophilia models by Siner, Joshua I, Samelson-Jones, Benjamin J, Crudele, Julie M, French, Robert A, Lee, Benjamin J, Zhou, Shanzhen, Merricks, Elizabeth, Raymer, Robin, Nichols, Timothy C, Camire, Rodney M, Arruda, Valder R

    Published in JCI insight (06-10-2016)
    “…Processing by the proprotein convertase furin is believed to be critical for the biological activity of multiple proteins involved in hemostasis, including…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Human Factor VIII Variants with Diminished PACE-Furin Cleavage Exhibit Increased Biological Activity and Therapeutic Efficacy by Nguyen, Giang N., Siner, Joshua I., Davidson, Robert J., Arruda, Valder R., Camire, Rodney M., Sabatino, Denise E.

    Published in Blood (06-12-2014)
    “…During intracellular processing, factor VIII (FVIII) undergoes proteolysis at multiple sites with the most predominant cleavage at a Paired basic Amino acid…”
    Get full text
    Journal Article
  7. 7

    Unexpected Role of PACE/Furin Cleavage Site in FVIII Biology: Implications for Hemophilia a Therapy by Siner, Joshua I, Crudele, Julie M, Connolly, Courtney T, Zhou, Shangzhen, Merricks, Elizabeth P., Nichols, Timothy C., Camire, Rodney M., Arruda, Valder R.

    Published in Blood (06-12-2014)
    “…The paired basic amino acid cleaving enzyme (PACE)/Furin is a protein convertase system that plays a vital role in several biological processes, including…”
    Get full text
    Journal Article
  8. 8

    Bioengineering Factor VIII B-Domain Sequences Improves Function and Efficacy in Hemophilia A Models by Siner, Joshua I, Iacobelli, Nicholas P, Ivanciu, Lacramioara, Sabatino, Denise E., Poncz, Mortimer, Camire, Rodney M., Arruda, Valder R

    Published in Blood (16-11-2012)
    “…Abstract 2208 We previously reported that recombinant canine B-domain deleted factor VIII (FVIII) was expressed predominantly (>75%) as a single-chain protein…”
    Get full text
    Journal Article
  9. 9

    Tolerance Induction To FIX Padua With AAV Liver Gene Transfer In Inhibitor-Prone Hemophilia B Dogs by Crudele, Julie M, Finn, Jonathan D, Martin, Nicholas B, Siner, Joshua I, Chen, Yifeng, Zhou, Shangzhen, Niemeyer, Glenn, Lothrop, Clinton D., Mingozzi, Federico, High, Katherine A., Arruda, Valder R.

    Published in Blood (15-11-2013)
    “…Emerging data from early phase clinical studies of AAV gene therapy for hemophilia B (HB) (factor IX [FIX] deficiency) show sustained expression of therapeutic…”
    Get full text
    Journal Article
  10. 10

    Insights Into the Mechanism of Zymogen Protein C Protection Against Cancer Progression by Crudele, Julie M, Van Sluis, Geerte L., Margaritis, Paris, Siner, Joshua I, Sliozberg, Michael, Maurer, Jenna, Faella, Armida, Zhou, Shangzhen, High, Katherine A., Esmon, Charles T, Spek, C. Arnold, Arruda, Valder R

    Published in Blood (16-11-2012)
    “…Abstract 3350 Cancer is frequently associated with activation of coagulation, and a procoagulant state facilitates tumor metastasis. Recent studies have…”
    Get full text
    Journal Article